We are monitoring the impact of COVID-19 on CRO Services Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6962
Share on
Share on

Global CRO Services Market Size, Share, Trends and Growth Analysis Report – Segmented By Type, Therapeutic Area, End User and Region - Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 6962
Pages: 175

Global CRO Services Market Size (2020 to 2025)

The global CRO Services market size is anticipated to grow at a 6.66% CAGR from 2020 to 2025. It is estimated that the global market was valued at USD 36.9 billion in 2020 and is relied upon to achieve USD 50.9 billion by 2025.

A CRO is a company that provides support to the pharmaceutical, biotechnology, and medical devices market in the form of research services outsourced on a contract basis. The services provided by CRO include clinical trials, prediscovery research, CMS, post-marketing services, and laboratory services. CRO is now expanding their work by assisting companies through all stages of the development of drugs. There has an increased advancement in technology used by CRO services, which have made the market more popular. Rapid globalization of important countries has helped the Contract Research Organizations services market to build a place in this sector. Pharmaceutical Companies value the importance of cybersecurity and thus want to protect the data related to clinical trials making the CRO services market less popular. Recently the Contract Research Organization services have started to use wearable devices for making the process easier and more efficient. India and China will play a significant role in the growth of the market.

MARKET DRIVERS

The significant factors contributing to the growth of the market is the increase in research and development of these services. The rising government initiatives have boosted the research being done in this market. Private companies have also started to invest more in these services due to its vast potential in the future. There is an increase in the number of clinical trials globally, which has boosted the market growth. The rise in the geriatric population worldwide, especially in the European and Asia Pacific regions, has ensured the development of this market in the future. The prevalence of chronic diseases due to the rise in population has also helped in the growth of this market. There is an increased outsourcing of the early phase clinical trials to reduce the expenses and boost the profits. The companies try to avoid high costs by reducing the process and product validation time and thus fuelling the growth of the market.

From an operational point of view, cybersecurity is becoming increasingly important. Clinical trial sponsors are particularly apprehensive about keeping their data private, especially after a recent breach involving clinical data. Businesses are concerned about what happens if their data is stolen and if it could harm R&D activities. Pharmaceuticals and life sciences companies using CROs to protect their test data are now emphasizing new operational strategies. The factors, as mentioned above, are slowly degrading the demand of the market.

Demand for CROs has increased as health facilities have unlocked various benefits from conventional research organizations to commercial businesses. As demand for CROs has increased, investors have identified tremendous growth opportunities in CROs. The increase in the number of investors involved in the development of research advisory organizations is likely to provide several options for the growth of contract research organization services.

CROs are now expanding their target market by expanding and deepening solutions throughout the life cycle of drug development. Increased investment in technology and big data will continue to play an important role. Most importantly, wearable devices, a potentially disruptive technology, offer significant market opportunities, and recently, CROs have begun to utilize data from mobile medical wearable devices to improve data quality and test efficiency, which is providing lucrative opportunities for the growth of contract research organization service market during the forecast period.

MARKET RESTRAINTS

The significant factors that restrict the growth of contract research organization services are the lack of qualified scientists and difficulties in assigning staff expertise for specific projects.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Type, Therapeutic Area and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This research report on the Global CRO Services Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2025.

CRO Services Market – By Type

  • Clinical Research Services         
  • Phase I Clinical Research Services        
  • Phase II Clinical Research Services       
  • Phase III Clinical Research Services      
  • Phase IV Clinical Research Services      
  • Early-Phase Development Services                
  • Discovery Studies       
  • Chemistry, Manufacturing, & Control (CMC)     
  • Preclinical Services      
    • Pharmacokinetics/Pharmacodynamics (PK/PD)
    • Toxicology Testing Services
    • Other Preclinical Services
  • Laboratory Services               
  • Bioanalytical Testing Services    
  • Analytical Testing Services       
    • Physical Characterization
    • Raw Material Testing
    • Batch-Release Testing
    • Stability Testing
    • Other Analytical Testing Services
  • Consulting Services         

CRO Services Market – By Therapeutic Area

  • Oncology
  • CNS
  • Cardiovascular      

CRO Services Market – By End User

  • Pharmaceutical
  • Biopharmaceutical
  • Medical Device Companies

CRO Services Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America has the largest share in the global market. The large share of this regional segment can be credited to its high-quality pharmaceutical industry standards, swift growth in the biosimilars and biologics market, increase in demand for outsourcing services by pharmaceutical and biopharmaceutical companies, and rise in the number of clinical trials in this region.

The market in the Asia-Pacific region is expected to grow the most in the coming years. It is mainly due to the rapid growth in the pharmaceutical industry, favorable government policies, an increase in the number of pharmaceutical companies establishing manufacturing facilities, and lower cost for clinical trials in the region.

NOTABLE COMPANIES IN THE MARKET

Some of the companies dominating the Global CRO Services Market are Quintiles Transnational Holdings Inc., Laboratory Corporation of America Holdings, Pharmaceutical Product DevelopmentPAREXEL International CorporationICON PlcPRA Health Sciences Inc., InVentiv Health Inc., Charles River Laboratories International Inc., INC Research Holdings Inc., and Wuxi PharmaTech.

RECENT DEVELOPMENTS IN CRO SERVICES INDUSTRY:

  • In April 2019, FHI 360 has launched a new CRO service, called FHI Clinical. The company focuses on helping companies in the hard-to-reach market and settings of limited resources.
  • In 2018, Cereno Scientific collaborated with CRO ‘OCT’ to enhance business operations and increase productivity.
  • In August 2017, Chiltern was acquired by LabCorp. The acquisition will help LabCorp become a market leader in CROs by expanding mid-market biopharmaceuticals and improving medical device operations.
  • In July 2017, Mapi Group was acquired by ICON; the acquisition will help boost ICON's business, as well as add Analytics, real-world data, significant trading presence, and regulatory expertise.
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type
      1. Clinical Research Services                 
      2. Phase I Clinical Research Services              
      3. Phase II Clinical Research Services             
      4. Phase III Clinical Research Services           
      5. Phase IV Clinical Research Services           
      6. Early-Phase Development Services                              
      7. Discovery Studies             
      8. Chemistry, Manufacturing, & Control (CMC)        
      9. Preclinical Services           
        1. Pharmacokinetics/Pharmacodynamics (PK/PD)
        2. Toxicology Testing Services
        3. Other Preclinical Services
      10. Laboratory Services                             
      11. Bioanalytical Testing Services      
      12. Analytical Testing Services            
        1. Physical Characterization
        2. Raw Material Testing
        3. Batch-Release Testing
        4. Stability Testing
        5. Other Analytical Testing Services
      13. Consulting Services                
      14. Y-o-Y Growth Analysis, By Type
      15. Market Attractiveness Analysis, By Type
      16. Market Share Analysis, By Type
    2. By Therapeutic Area
      1. Oncology
      2. CNS
      3. Cardiovascular           
      4. Y-o-Y Growth Analysis, By Therapeutic Area
      5. Market Attractiveness Analysis, By Therapeutic Area
      6. Market Share Analysis, By Therapeutic Area
    3. By End User
      1. Pharmaceutical
      2. Biopharmaceutical
      3. Medical Device Companies
      4. Y-o-Y Growth Analysis, By End User
      5. Market Attractiveness Analysis, By End User
      6. Market Share Analysis, By End User
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Component Type
        3. By Form
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Component Type
        3. By Form
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Component Type
        3. By Form
    2. North America
      1. Introduction
      2. US
      3. Canada
    3. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
    4. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
    6. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Quintiles Transnational Holdings Inc.
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Laboratory Corporation of America Holding
    3. Pharmaceutical Product Development
    4. PAREXEL International Corporation
    5. ICON Plc
    6. PRA Health Sciences Inc.
    7. InVentiv Health Inc.
    8. Charles River Laboratories International Inc.
    9. INC Research Holdings Inc.
    10. Wuxi PharmaTech
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures 
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type and Technology along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global CRO Services Market, By Region, From 2020 to 2025 (USD Million)
  2. Global CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  3. Global Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  4. Global Phase I Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  5. Global Phase II Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  6. Global Phase III Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  7. Global Phase IV Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  8. Global BioAnalytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  9. Global Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  10. Global Consulting Services Market, By Region, From 2020 to 2025 (USD Million)
  11. Global CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  12. Global Oncology Market, By Region, From 2020 to 2025 (USD Million)
  13. Global CNS Market, By Region, From 2020 to 2025 (USD Million)
  14. Global Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  15. Global CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  16. Global Pharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  17. Global Biopharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  18. Global Medical Device Companies Market, By Region, From 2020 to 2025 (USD Million)
  19. Global CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  20. Global Physical Characterization Market, By Region, From 2020 to 2025 (USD Million)
  21. Global Raw Material Testing Market, By Region, From 2020 to 2025 (USD Million)
  22. Global Batch-Release Testing Market, By Region, From 2020 to 2025 (USD Million)
  23. Global Stability Testing Market, By Region, From 2020 to 2025 (USD Million)
  24. Global Other Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  25. Global CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  26. Global Pharmacokinetics/Pharmacodynamics (PK/PD) Market, By Region, From 2020 to 2025 (USD Million)
  27. Global Toxicology Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  28. Global Other Preclinical Services Market, By Region, From 2020 to 2025 (USD Million)
  29. North America CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  30. North America Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  31. North America Phase I Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  32. North America Phase II Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  33. North America Phase III Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  34. North America Phase IV Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  35. North America BioAnalytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  36. North America Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  37. North America Consulting Services Market, By Region, From 2020 to 2025 (USD Million)
  38. North America CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  39. North America Oncology Market, By Region, From 2020 to 2025 (USD Million)
  40. North America CNS Market, By Region, From 2020 to 2025 (USD Million)
  41. North America Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  42. North America CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  43. North America Pharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  44. North America Biopharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  45. North America Medical Device Companies Market, By Region, From 2020 to 2025 (USD Million)
  46. United States CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  47. United States CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  48. United States CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  49. Canada CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  50. Canada CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  51. Canada CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  52. North America CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  53. North America Physical Characterization Market, By Region, From 2020 to 2025 (USD Million)
  54. North America Raw Material Testing Market, By Region, From 2020 to 2025 (USD Million)
  55. North America Batch-Release Testing Market, By Region, From 2020 to 2025 (USD Million)
  56. North America Stability Testing Market, By Region, From 2020 to 2025 (USD Million)
  57. North America Other Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  58. United States CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  59. Canada CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  60. North America CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  61. North America Pharmacokinetics/Pharmacodynamics (PK/PD) Market, By Region, From 2020 to 2025 (USD Million)
  62. North America Toxicology Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  63. North America Other Preclinical Services Market, By Region, From 2020 to 2025 (USD Million)
  64. United States CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  65. Canada CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  66. Europe CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  67. Europe Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  68. Europe Phase I Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  69. Europe Phase II Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  70. Europe Phase III Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  71. Europe Phase IV Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  72. Europe BioAnalytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  73. Europe Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  74. Europe Consulting Services Market, By Region, From 2020 to 2025 (USD Million)
  75. Europe CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  76. Europe Oncology Market, By Region, From 2020 to 2025 (USD Million)
  77. Europe CNS Market, By Region, From 2020 to 2025 (USD Million)
  78. Europe Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  79. Europe CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  80. Europe Pharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  81. Europe Biopharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  82. Europe Medical Device Companies Market, By Region, From 2020 to 2025 (USD Million)
  83. U.K. CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  84. U.K. CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  85. U.K. CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  86. Germany CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  87. Germany CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  88. Germany CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  89. France CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  90. France CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  91. France CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  92. Italy CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  93. Italy CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  94. Italy CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  95. Spain CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  96. Spain CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  97. Spain CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  98. Europe CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  99. Europe Physical Characterization Market, By Region, From 2020 to 2025 (USD Million)
  100. Europe Raw Material Testing Market, By Region, From 2020 to 2025 (USD Million)
  101. Europe Batch-Release Testing Market, By Region, From 2020 to 2025 (USD Million)
  102. Europe Stability Testing Market, By Region, From 2020 to 2025 (USD Million)
  103. Europe Other Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  104. U.K. CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  105. Germany CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  106. France CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  107. Italy CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  108. Spain CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  109. Europe CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  110. Europe Pharmacokinetics/Pharmacodynamics (PK/PD) Market, By Region, From 2020 to 2025 (USD Million)
  111. Europe Toxicology Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  112. Europe Other Preclinical Services Market, By Region, From 2020 to 2025 (USD Million)
  113. U.K. CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  114. Germany CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  115. France CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  116. Italy CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  117. Spain CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  118. Asia Pacific CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  119. Asia Pacific Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  120. Asia Pacific Phase I Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  121. Asia Pacific Phase II Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  122. Asia Pacific Phase III Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  123. Asia Pacific Phase IV Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  124. Asia Pacific BioAnalytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  125. Asia Pacific Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  126. Asia Pacific Consulting Services Market, By Region, From 2020 to 2025 (USD Million)
  127. Asia Pacific
  128. Asia Pacific
  129. Asia Pacific CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  130. Asia Pacific Oncology Market, By Region, From 2020 to 2025 (USD Million)
  131. Asia Pacific CNS Market, By Region, From 2020 to 2025 (USD Million)
  132. Asia Pacific Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  133. Asia Pacific CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  134. Asia Pacific Pharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  135. Asia Pacific Biopharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  136. Asia Pacific Medical Device Companies Market, By Region, From 2020 to 2025 (USD Million)
  137. Japan CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  138. Japan CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  139. Japan CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  140. China CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  141. China CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  142. China CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  143. India CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  144. India CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  145. India CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  146. Australia CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  147. Australia CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  148. Australia CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  149. South Korea CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  150. South Korea CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  151. South Korea CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  152. Asia Pacific CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  153. Asia Pacific Physical Characterization Market, By Region, From 2020 to 2025 (USD Million)
  154. Asia Pacific Raw Material Testing Market, By Region, From 2020 to 2025 (USD Million)
  155. Asia Pacific Batch-Release Testing Market, By Region, From 2020 to 2025 (USD Million)
  156. Asia Pacific Stability Testing Market, By Region, From 2020 to 2025 (USD Million)
  157. Asia Pacific Other Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  158. Japan CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  159. China CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  160. India CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  161. Australia CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  162. Asia Pacific CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  163. Asia Pacific Pharmacokinetics/Pharmacodynamics (PK/PD) Market, By Region, From 2020 to 2025 (USD Million)
  164. Asia Pacific Toxicology Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  165. Asia Pacific Other Preclinical Services Market, By Region, From 2020 to 2025 (USD Million)
  166. Japan CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  167. China CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  168. India CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  169. Australia CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  170. Latin America CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  171. Latin America Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  172. Latin America Phase I Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  173. Latin America Phase II Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  174. Latin America Phase III Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  175. Latin America Phase IV Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  176. Latin America BioAnalytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  177. Latin America Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  178. Latin America Consulting Services Market, By Region, From 2020 to 2025 (USD Million)
  179. Latin America CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  180. Latin America Oncology Market, By Region, From 2020 to 2025 (USD Million)
  181. Latin America CNS Market, By Region, From 2020 to 2025 (USD Million)
  182. Latin America Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  183. Latin America CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  184. Latin America Pharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  185. Latin America Biopharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  186. Latin America Medical Device Companies Market, By Region, From 2020 to 2025 (USD Million)
  187. Brazil CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  188. Brazil CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  189. Brazil CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  190. Argentina CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  191. Argentina CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  192. Argentina CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  193. Mexico CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  194. Mexico CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  195. Mexico CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  196. Rest of Latin America
  197. Rest of Latin America CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  198. Rest of Latin America CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  199. Rest of Latin America CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  200. Latin America CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  201. Latin America Physical Characterization Market, By Region, From 2020 to 2025 (USD Million)
  202. Latin America Raw Material Testing Market, By Region, From 2020 to 2025 (USD Million)
  203. Latin America Batch-Release Testing Market, By Region, From 2020 to 2025 (USD Million)
  204. Latin America Stability Testing Market, By Region, From 2020 to 2025 (USD Million)
  205. Latin America Other Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  206. Brazil CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  207. Argentina CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  208. Mexico CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  209. Latin America CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  210. Latin America Pharmacokinetics/Pharmacodynamics (PK/PD) Market, By Region, From 2020 to 2025 (USD Million)
  211. Latin America Toxicology Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  212. Latin America Other Preclinical Services Market, By Region, From 2020 to 2025 (USD Million)
  213. Brazil CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  214. Argentina CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  215. Mexico CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  216. Middle East and Africa
  217. Middle East and Africa CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  218. Middle East and Africa Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  219. Middle East and Africa Phase I Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  220. Middle East and Africa Phase II Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  221. Middle East and Africa Phase III Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  222. Middle East and Africa Phase IV Clinical Research Services Market, By Region, From 2020 to 2025 (USD Million)
  223. Middle East and Africa BioAnalytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  224. Middle East and Africa Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  225. Middle East and Africa Consulting Services Market, By Region, From 2020 to 2025 (USD Million)
  226. Middle East and Africa CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  227. Middle East and Africa Oncology Market, By Region, From 2020 to 2025 (USD Million)
  228. Middle East and Africa CNS Market, By Region, From 2020 to 2025 (USD Million)
  229. Middle East and Africa Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  230. Middle East and Africa CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  231. Middle East and Africa Pharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  232. Middle East and Africa Biopharmaceutical Market, By Region, From 2020 to 2025 (USD Million)
  233. Middle East and Africa Medical Device Companies Market, By Region, From 2020 to 2025 (USD Million)
  234. Middle East
  235. Middle East CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  236. Middle East CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  237. Middle East CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  238. Africa
  239. Africa CRO Services Market, By Type, From 2020 to 2025 (USD Million)
  240. Africa CRO Services Market, By Therapeutic Area, From 2020 to 2025 (USD Million)
  241. Africa CRO Services Market, By End-User, From 2020 to 2025 (USD Million)
  242. Middle East and Africa CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  243. Middle East and Africa Physical Characterization Market, By Region, From 2020 to 2025 (USD Million)
  244. Middle East and Africa Raw Material Testing Market, By Region, From 2020 to 2025 (USD Million)
  245. Middle East and Africa Batch-Release Testing Market, By Region, From 2020 to 2025 (USD Million)
  246. Middle East and Africa Stability Testing Market, By Region, From 2020 to 2025 (USD Million)
  247. Middle East and Africa Other Analytical Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  248. Middle East CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  249. Africa CRO Services Market, By Analytical Testing Services, From 2020 to 2025 (USD Million)
  250. Middle East and Africa CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  251. Middle East and Africa Pharmacokinetics/Pharmacodynamics (PK/PD) Market, By Region, From 2020 to 2025 (USD Million)
  252. Middle East and Africa Toxicology Testing Services Market, By Region, From 2020 to 2025 (USD Million)
  253. Middle East and Africa Other Preclinical Services Market, By Region, From 2020 to 2025 (USD Million)
  254. Middle East CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)
  255. Africa CRO Services Market, By Preclinical Services, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample